• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

World Market for Prescription Arthritis Treatments (NSAIDs, DMARDs, BRMs and Immunosuppressants), The

$150.00 – $300.00

Clear
SKU: KLI6665486 Categories: Pharmaceuticals Market Research, Prescription Drugs Market Reports Pages: 150
  • Description
  • Table of Contents
  • Latest reports

Description

Arthritis is one of the most common human ailments worldwide. Arthritis is a complex family of musculoskeletal disorders with many causes that are not fully understood. The most crippling of the arthritis family is rheumatoid arthritis, which is an autoimmune disease. Successful treatment of arthritis has resulted from a growing array of therapies available to physicians.

While these pharmaceutical products are still used regularly, new disease-modifying therapies have produced the most impressive results in treating more severe types of arthritis. Additionally, combination therapies continue to grow in preference and offer exciting results in disease management.
This Kalorama Information report, The World Market for Prescription Arthritis Treatments, details the market for these treatments. The report provides market sizes and forecasts for the following categories of treatments:

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  • Disease Modifying Anti-Rheumatic Drugs (DMARDs)
  • Biologic Response Modifiers (BRMs) and Immunosuppressants

For each category, the report breaks down the regional market (US, Europe, Japan, Rest of World), lists major products, and provides market share among major competitors.

There are several issues and trends that are shaping this market. Some of the topics, discussed in this report include:

  • US Economic Impact of Arthritis
  • World Economic Impact of Arthritis
  • Obesity and Arthritis
  • Trends in Insurance and Reimbursement
  • Threat to Anti-TNF Dominance
  • ADAM-12 Gene Discovery
  • New Pricing Structure in Germany

The information and analysis presented in this report are based on extensive interviews with senior management of top companies in the worldwide arthritis treatment market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with over 20 industry executives and product managers to validate and obtain expert opinion on current and future trends in the worldwide prescription arthritis treatment market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.

The following companies are profiled in the report:

  • Abbott Laboratories
  • Amgen, Inc
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb
  • Galapagos NV
  • Genentech, Inc.
  • Horizon Pharma
  • Janssen Biotech, Inc
  • Novartis International AG
  • Pfizer, Inc.
  • Roche
  • Regeneron
  • UCB

All market data pertains to the worldwide market at the manufacturers’ level. Data are expressed in current U.S. dollars. A geographic breakdown is also included for US, Europe, Japan and Rest of World total market and in each drug type segment. The base year for data was 2011. Historical data are provided for each of the years 2009 to 2011, and forecast data are provided for each of the years 2011 through 2016. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2011 base year.

All Kalorama Information reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.

For Kalorama’s take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information’s Key Point Blog at http://kaloramakeypoint.blogspot.com/

Table of Contents

TABLE OF CONTENTS CHAPTER ONE: EXECUTIVE SUMMARY

  • Introduction
  • Scope and Methodology
  • Product Market Summary
  • Issues and Trends Affecting Market
  • Competitor Analysis

CHAPTER TWO: INTRODUCTION

  • Overview
  • Local Joint Disorder Function
    • Etiology and Pathogenesis
    • Clinical Manifestations
  • Osteoarthritis
    • Etiology and Pathogenesis
    • Clinical Manifestations
    • Treatment
  • Infectious Arthritis
    • Etiology and Pathogenesis
    • Clinical Manifestations
    • Systemic Disorders of Joint Function
  • Rheumatoid Arthritis
    • Etiology and Pathogenesis
    • Clinical Manifestations
  • Ankylosing Spondylitis
    • Clinical Manifestations
  • Psoriatic Arthritis
    • Clinical Manifestations
  • Enteropathic Arthritis
    • Clinical Manifestations
  • Adult Onset Still Disease
    • Clinical Manifestations
  • Juvenile Rheumatoid Arthritis
    • Clinical Manifestations
  • Still Disease
  • Polyarticular Onset
  • World Demographics

CHAPTER THREE: WORLDWIDE NON-STEROIDAL ANTI-INFLAMMATORY DRUG MARKET

  • Product Description
  • Market Forecast and Growth
  • Markets by Geographical Region
    • United States
    • Europe
    • Japan
    • Rest of World
  • Competitive Landscape

CHAPTER FOUR: WORLDWIDE DISEASE-MODIFYING ANTI-RHEUMATIC DRUG TREATMENT MARKETS

  • Product Descriiption
    • Sulfasalazine (Azulfidine-Pfizer)
    • Gold Compounds
    • Penicillamine (Cuprimine-Merck)
    • Chloroquine (Aralen-Sanofi-Aventis)
    • Methotrexate (Trexall-Duramed; Rheumatrex-DAVA Pharmaceuticals)
    • Leflunomide (Arava-Sanofi-Aventis)
  • Market Forecast and Growth
  • Markets by Geographical Region
    • United States
    • Europe
    • Japan
    • Rest of World
  • Competitive Landscape

CHAPTER FIVE: WORLDWIDE BIOLOGICAL RESPONSE MODIFIERS AND IMMUNOSUPPRESSIVE DRUG MARKETS

  • Description
  • Tumor Necrosis Factor
  • Glucocorticoids
  • Azathioprine (Azasan-Salix)
  • Adalimumab (Humira-Abbott)
  • Anakinra (Kineret-Amgen)
  • Basiliximab (Simulect-Novartis)
  • Daclizumab (Zenapax-Roche)
  • Etanercept (Enbrel-Amgen)
  • Infliximab (Remicade-Janssen Biotech)
  • Rituximab (Rituxan-Biogen Idec)
  • Abatacept (Orencia-Bristol-Myers Squibb)
  • Market forecast and Growth
  • Markets by Geographical Region
    • United States
    • Europe
    • Japan
    • Rest of World
  • Competitive Landscape

CHAPTER SIX: WORLDWIDE ARTHRITIS TREATMENT MARKET SUMMARY AND COMPETITIVE ANALYSIS

  • Market Overview
  • Product Market Summary
  • Product Market Analysis by Geographical Region
  • 6 Worldwide Arthritis Treatment Products Competitive Analysis

CHAPTER SEVEN: ARTHRITIS RESEARCH AND DEVELOPMENT TREATMENTS

  • Overview
  • Duexis
  • Gel-One
  • ACZ
  • Apremilast
  • Fostamatinib
  • Lodotra
  • Stelara
  • Tofacitinib

CHAPTER EIGHT: ARTHRITIS TREATMENTS ISSUES AND TRENDS

  • Overview
  • US Economic Impact of Arthritis
  • World Economic Impact of Arthritis
  • Obesity and Arthritis
  • Trends in Insurance and Reimbursement
  • Threat to Anti-TNF Dominance
  • ADAM- Gene Discovery
  • New Pricing Structure in Germany

CHAPTER SEVEN: CONCLUSIONS

  • Conclusion One
  • Conclusion Two
  • Conclusion Three
  • Conclusion Four
  • Conclusion Five

CHAPTER EIGHT: COMPANY PROFILES

  • Introduction
  • Abbott Laboratories
  • Amgen, Inc
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb
  • Galapagos NV
  • Genentech, Inc.
  • Horizon Pharma
  • Janssen Biotech, Inc
  • Novartis International AG
  • Pfizer, Inc.
  • Roche
  • Regeneron
  • UCB

LIST OF COMPANIES

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Summary Table: Total World Arthritis Treatment Revenue and Growth Rate by Drug Type 2011 ($millions)
  • Summary Figure:The World Prescription Arthritis Treatments Market Share Summary 2011

CHAPTER TWO: INTRODUCTION

  • Table 2-1: Total Global Population by Selected Geographical Region, 2000 – 2050
  • Table 2-2 World Prevalence of Rheumatoid Arthritis by Region
  • Figure 2-1:: World Prevalence of Rheumatoid Arthritis, Percent by Region

CHAPTER THREE: WORLDWIDE NON-STEROIDAL ANTI-INFLAMMATORY DRUG MARKET

  • Table 3-1: Select Marketed Non-steroidal Anti-inflammatory Drugs
  • Table 3-2 Market Size and Growth for NSAIDs in the Global Arthritis Treatment Market 2009-2016 ($millions)
  • Figure 3-1 Market Size and Growth for NSAIDs in the Global Arthritis Treatment Market 2009-2016 ($millions)
  • Table 3-3: The Worldwide Market for NSAIDs by Geographical Region (US, Europe, ROW) 2009-2016
  • Figure 3-2: The Worldwide Market for NSAIDs Products by Region (US, Europe, Japan, ROW), 2011
  • Figure 3-3: The Worldwide Market for NSAIDs Products by Region (US, Europe, Japan, ROW), 2016
  • Table 3-4: The Worldwide NSAIDs Product Market Share by Supplier 2011
  • Figure 3-4: The Worldwide NSAIDs Product Market Share by Supplier 2011

CHAPTER FOUR: WORLDWIDE DISEASE-MODIFYING ANTI-RHEUMATIC DRUG TREATMENT MARKETS

  • Table 4-1: Selected Prescription Disease Modifying Anti-Rheumatic Drugs
  • Table 4-2: Market Size and Growth for DMARDs in the Global Arthritis Treatment Market 2009-2016 ($millions)
  • Figure 4-1: Market Size and Growth for NSAIDs in the Global Arthritis Treatment Market 2009-2016 ($millions)

CHAPTER FIVE: WORLDWIDE BIOLOGICAL RESPONSE MODIFIERS AND IMMUNOSUPPRESSIVE DRUG MARKETS

  • Table 5-1: Selected Prescription Immunosuppressant and Other Biologic Drugs
  • Table 5-2 Market Size and Growth for BMRs and Immunosuppressants in the Global Arthritis Treatment Market 2009-2016 ($millions)
  • Figure 5-1 Market Size and Growth for BRMs and Immunosuppressants in the Global Arthritis Treatment Market 2009-2016 ($millions)
  • Table 5-3: The Worldwide Market for BRMs by Geographical Region (US, Europe, Japan, ROW) 2009-2016
  • Figure 5-2: The Worldwide Market for BRM Products by Region (US, Europe, Japan, ROW), 2011
  • Figure 5-3: The Worldwide Market for BRM Products by Region (US, Europe, Japan, ROW), 2016
  • Table 5-4: The World Biologic Response Modifiers Arthritis Treatment nd Market Share by Supplier 2011
  • Figure 5-4: The Worldwide BRMs and Immunosuppressives Product Market Share by Supplier 2011

CHAPTER SIX: WORLDWIDE ARTHRITIS TREATMENT MARKET SUMMARY AND COMPETITIVE ANALYSIS

  • Table 6-1: Total World Prescription Arthritis Treatment Revenue and Growth Rate by Drug Type 2011
  • Figure 6-1: The World Prescription Arthritis Treatments Market Share Summary 2011
  • Table 6-3: The World Market for Prescription Arthritis Treatments, by Geographic Region, 2011
  • Figure 6-2: The World Market for Prescription Rheumatoid Arthritis, by Geographic Region, 2011

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    Rheumatoid Arthritis: The 45 Market in the United States for Drugs and Biologics

    $2,246.00 – $4,492.00
  • Placeholder image

    Advanced Drug Delivery: Technologies, Applications, and Markets

    $2,625.00 – $5,250.00
  • Placeholder image

    Type II Diabetes: The 45 Market in the United States for Drugs and Diagnostics

    $2,995.00 – $5,990.00
  • Placeholder image

    Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
DNA Microarray Market Trends (Installed Base, Applications, Purchase Plans and...US Pharmaceutical, Medical Device, Diagnostics Markets
Scroll to top